|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Mar 09, 2013 |
Title |
Depletion of Jak2V617F MPN-propagating stem cells by interferon-alpha in a murine model of polycythemia vera |
Organism |
Mus musculus |
Experiment type |
Expression profiling by array
|
Summary |
Interferon alpha (IFNa) is an effective treatment for patients with myeloproliferative neoplasms (MPN). In addition to inducing hematological responses in most MPN patients, IFNa reduces the JAK2V617F allelic burden and can render the JAK2V617F mutant clone undetectable in some patients. The precise mechanism underlying these responses is incompletely understood and whether the molecular responses that are seen occur due to the effects of IFNa on JAK2V617F mutant stem cells is debated. Using a murine model of Jak2V617F MPN, we investigated the effects of IFNa on Jak2V617F MPN-propagating stem cells in vivo. We report that IFNa treatment induces hematological responses in the model and causes depletion of Jak2V617F MPN-propagating cells over time, impairing disease transplantation. We demonstrate that IFNa treatment induces cell-cycle activation of Jak2V617F mutant long-term hematopoietic stem cells (LT-HSC) and promotes a predetermined erythroid-lineage differentiation program. These findings provide insights into the differential effects of IFNa on Jak2V617F mutant and normal hematopoiesis and suggest that IFNa achieves molecular remissions in MPN patients through its effects on MPN stem cells. Furthermore, these results support combinatorial therapeutic approaches in MPN, by concurrently depleting dormant JAK2V617F MPN-propagating stem cells with IFNa and targeting the proliferating downstream progeny with JAK2-inhibitors or cytotoxic chemotherapy.
|
|
|
Overall design |
HSC-enriched population from WT (CD45.1) or Jak2VF knockin (CD45.2), after 4 weeks of interferon alpha or vehicle treatment. N=4 per condition
|
|
|
Contributor(s) |
Mullally A, Bruedigam C, Poveromo LP, Heidel FH, Purdon A, Vu T, Austin R, Heckl D, Breyfogle LJ, Paine Kuhn C, Kalaitzidis D, Armstrong SA, Williams DA, Hill GR, Ebert BL, Lane SW |
Citation(s) |
23487027 |
|
Submission date |
Mar 07, 2013 |
Last update date |
Jun 14, 2018 |
Contact name |
Steven Lane |
Organization name |
QIMR
|
Street address |
300 Herston Rd
|
City |
Brisbane |
ZIP/Postal code |
4064 |
Country |
Australia |
|
|
Platforms (1) |
GPL6885 |
Illumina MouseRef-8 v2.0 expression beadchip |
|
Samples (16)
|
|
Relations |
BioProject |
PRJNA192679 |
Supplementary file |
Size |
Download |
File type/resource |
GSE44961_RAW.tar |
3.1 Mb |
(http)(custom) |
TAR |
GSE44961_non-normalized.txt.gz |
2.6 Mb |
(ftp)(http) |
TXT |
Processed data included within Sample table |
|
|
|
|
|